Hi Jeff,
I was wondering why you opted for the lithium orotate rather than the carbonate as used in the study.... also are you being monitored for blood lithium levels to be 0.4 mg/L as mentioned in the study?
I know it is natural to be skeptical about this, but if I'm not mistaken it was mentioned that "there was no progression in the lithium group, whereas there was a 50% decline in 3 months in the riluzole group". That is a pretty massive statement, and my first reaction was to be skeptical as well. But since hearing the study has been accepted into PNAS my hope has risen enormously. I say that because I have been a biochemistry researcher into Type 2 Diabetes and known how prestigious this journal is, and how precise and important a study must be before it is accepted.
And as for side effects, bring on any side effect under the sun, as long as it stops progression I don't care.